Paper36725110
The biology of E-selectin ligands in leukemogenesis.
Ales E and 1 other. Adv Cancer Res, 2023. Cited by 23 papers, by iCite.
Cite this record
ConductScience Library. The biology of E-selectin ligands in leukemogenesis. Papers, record 36725110. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36725110
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| E-Selectin | Major topic |
| Endothelial Cells | Major topic |
| Humans | |
| Cell Adhesion | |
| Glycoconjugates | |
| Ligands | |
| Leukemia | |
| Hematopoiesis |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01 HL107146 | NHLBI NIH HHS | United States | P01HL107146 | PubMed and NIH | NIH RePORTER |
| U01 CA225730 | NCI NIH HHS | United States | U01CA225730 | PubMed and NIH | NIH RePORTER |
References81
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14592840 | Adhesion to E-selectin promotes growth inhibition and apoptosis of human and murine hematopoietic progenitor cells independent of PSGL-1. | Blood | 2004 | https://conductscience.org/library/papers/14592840 | PubMed |
| 2 | 10580634 | CD43, a molecule with multiple functions. | Immunol Res | 1999 | https://conductscience.org/library/papers/10580634 | PubMed |
| 3 | 9298690 | Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer. | Glycoconj J | 1997 | https://conductscience.org/library/papers/9298690 | PubMed |
| 4 | 1711725 | Carbohydrate differentiation antigens: probable ligands for cell adhesion molecules. | Trends Biochem Sci | 1991 | https://conductscience.org/library/papers/1711725 | PubMed |
| 5 | 26933169 | Fulfilling Koch's postulates in glycoscience: HCELL, GPS and translational glycobiology. | Glycobiology | 2016 | https://conductscience.org/library/papers/26933169 | PubMed |
| 6 | 11095749 | A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells. | Proc Natl Acad Sci U S A | 2000 | https://conductscience.org/library/papers/11095749 | PubMed |
| 7 | 11374868 | Glycolipids support E-selectin-specific strong cell tethering under flow. | Biochem Biophys Res Commun | 2001 | https://conductscience.org/library/papers/11374868 | PubMed |
| 8 | 8621728 | Post-translational modifications of recombinant P-selectin glycoprotein ligand-1 required for binding to P- and E-selectin. | J Biol Chem | 1996 | https://conductscience.org/library/papers/8621728 | PubMed |
| 9 | 7678617 | Control of lymphocyte recirculation in man. II. Differential regulation of the cutaneous lymphocyte-associated antigen, a tissue-selective homing receptor for skin-homing T cells. | J Immunol | 1993 | https://conductscience.org/library/papers/7678617 | PubMed |
| 10 | 8547257 | Monosialogangliosides of human myelogenous leukemia HL60 cells and normal human leukocytes. 2. Characterization of E-selectin binding fractions, and structural requirements for physiological binding to E-selectin. | Biochemistry | 1996 | https://conductscience.org/library/papers/8547257 | PubMed |
| 11 | 26244810 | Large-Scale Identification of N-Glycan Glycoproteins Carrying Lewis x and Site-Specific N-Glycan Alterations in Fut9 Knockout Mice. | J Proteome Res | 2015 | https://conductscience.org/library/papers/26244810 | PubMed |
| 12 | 16998483 | Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells. | Nat Med | 2006 | https://conductscience.org/library/papers/16998483 | PubMed |
| 13 | 21659548 | Analysis of glycoprotein E-selectin ligands on human and mouse marrow cells enriched for hematopoietic stem/progenitor cells. | Blood | 2011 | https://conductscience.org/library/papers/21659548 | PubMed |
| 14 | 28330896 | Cell-Specific Variation in E-Selectin Ligand Expression among Human Peripheral Blood Mononuclear Cells: Implications for Immunosurveillance and Pathobiology. | J Immunol | 2017 | https://conductscience.org/library/papers/28330896 | PubMed |
| 15 | 15959517 | In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment. | Nature | 2005 | https://conductscience.org/library/papers/15959517 | PubMed |
| 16 | 9545353 | Comparison of promoters for the murine and human P-selectin genes suggests species-specific and conserved mechanisms for transcriptional regulation in endothelial cells. | J Biol Chem | 1998 | https://conductscience.org/library/papers/9545353 | PubMed |
| 17 | 10572097 | Divergent inducible expression of P-selectin and E-selectin in mice and primates. | Blood | 1999 | https://conductscience.org/library/papers/10572097 | PubMed |
| 18 | 10914548 | Expression of CD44 variant exons in acute myeloid leukemia is more common and more complex than that observed in normal blood, bone marrow or CD34+ cells. | Leukemia | 2000 | https://conductscience.org/library/papers/10914548 | PubMed |
| 19 | 15989959 | SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. | Cell | 2005 | https://conductscience.org/library/papers/15989959 | PubMed |
| 20 | 21827751 | CD44 and HCELL: preventing hematogenous metastasis at step 1. | FEBS Lett | 2011 | https://conductscience.org/library/papers/21827751 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42375024 | sVCAM-1 and Hematological Profiles Are Associated With CD4-Defined Disease Status in HIV Infection. | J Med Virol | 2026 | https://conductscience.org/library/papers/42375024 | PubMed |
| 41651416 | Writers and readers of sialylation in immunoregulation in cancer. | J Biol Chem | 2026 | https://conductscience.org/library/papers/41651416 | PubMed |
| 41619722 | A pan-cancer single-cell transcriptomic atlas of human bone metastases. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/41619722 | PubMed |
| 41360793 | Structure, function, and implications of fucosyltransferases in health and disease. | Nat Commun | 2025 | https://conductscience.org/library/papers/41360793 | PubMed |
| 41169544 | Chemical Strategies to Custom-Modify α(1→3)-Fucosylated Glycan Motifs of the Human Glycocalyx. | JACS Au | 2025 | https://conductscience.org/library/papers/41169544 | PubMed |
| 40683091 | Discovery and characterization of vertebrate sialoglycan-binding proteins. | Semin Immunol | 2025 | https://conductscience.org/library/papers/40683091 | PubMed |
| 40146612 | Realizing the promise of 'La Dolce Vita' via chemical biology: glycan-motif editing of sLeX for precision cancer therapeutics. | FEBS J | 2025 | https://conductscience.org/library/papers/40146612 | PubMed |
| 39628991 | When a negative (charge) is not a positive: sialylation and its role in cancer mechanics and progression. | Front Oncol | 2024 | https://conductscience.org/library/papers/39628991 | PubMed |
| 39053235 | Glycoengineering in antigen-specific immunotherapies. | Curr Opin Chem Biol | 2024 | https://conductscience.org/library/papers/39053235 | PubMed |
| 38840921 | The role of galectins in mediating the adhesion of circulating cells to vascular endothelium. | Front Immunol | 2024 | https://conductscience.org/library/papers/38840921 | PubMed |
| 38643279 | Leukemia circulation kinetics revealed through blood exchange method. | Commun Biol | 2024 | https://conductscience.org/library/papers/38643279 | PubMed |
| 38586333 | Potential new cancer biomarkers revealed by quantum chemistry associated with bioinformatics in the study of selectin polymorphisms. | Heliyon | 2024 | https://conductscience.org/library/papers/38586333 | PubMed |
| 38493006 | Targeting hematologic malignancies by inhibiting E-selectin: A sweet spot for AML therapy? | Blood Rev | 2024 | https://conductscience.org/library/papers/38493006 | PubMed |
| 38243063 | PSGL-1 decorated with sialyl Lewisa/x promotes high affinity binding of myeloma cells to P-selectin but is dispensable for E-selectin engagement. | Sci Rep | 2024 | https://conductscience.org/library/papers/38243063 | PubMed |
| 37958334 | The Role of the Microenvironment and Cell Adhesion Molecules in Chronic Lymphocytic Leukemia. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37958334 | PubMed |
| 37486674 | Identification of potential classes of glycoligands mediating dynamic endothelial adhesion of human tumor cells. | Glycobiology | 2023 | https://conductscience.org/library/papers/37486674 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SELE | 6401 | PubTator's text mining | https://conductscience.org/library/genes/6401 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36725110
GET https://conductscience.org/api/papers/v1/36725110/references?page=2